BIIB vs CON · P/E 21, rev $9.89B vs P/E 18, rev $1.90B
Biogen Inc (BIIB) versus Concentra Group Holdings Parent, Inc. (CON) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Concentra Group Holdings Parent, Inc. (CON) is a medical care facilities company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CON revenue for 2024-12-31 was $1.90B. Net income was $171.9M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. CON currently screens at market cap $3.18B and trailing P/E 17.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CON currently screens at market cap $3.18B and trailing P/E 17.9.
Not investment advice. Open the BIIB and CON stock pages for the full models.
Not investment advice.